Skip to content
← Back to this collection

PUBLICATIONS · 2202791

Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
1990 Sep
First author
Fisher B

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Fisher B
      type
      Author
    2. name
      Brown AM
      type
      Author
    3. name
      Dimitrov NV
      type
      Author
    4. name
      Poisson R
      type
      Author
    5. name
      Redmond C
      type
      Author
    6. name
      Margolese RG
      type
      Author
    7. name
      Bowman D
      type
      Author
    8. name
      Wolmark N
      type
      Author
    9. name
      Wickerham DL
      type
      Author
    10. name
      Kardinal CG
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Fisher B
      type
      Author
    2. name
      Brown AM
      type
      Author
    3. name
      Dimitrov NV
      type
      Author
    4. name
      Poisson R
      type
      Author
    5. name
      Redmond C
      type
      Author
    6. name
      Margolese RG
      type
      Author
    7. name
      Bowman D
      type
      Author
    8. name
      Wolmark N
      type
      Author
    9. name
      Wickerham DL
      type
      Author
    10. name
      Kardinal CG
      type
      Author
    bibliography ids
    1. nci-bib-b7d124945ee7caf3ab7130f5
    book metadata
    content sha256
    a98f4c8e6f170012aac8da6ccd3f6c0d2d18d2029c980f3ff424d29f2b94208b
    document type
    citation
    dois
    1. 10.1200/JCO.1990.8.9.1483
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:2202791
    immutable id
    pubmed:2202791@a98f4c8e6f170012aac8da6ccd3f6c0d2d18d2029c980f3ff424d29f2b94208b
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    Source null
    issn print
    0732-183X
    issue
    9
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    1483-96
    volume
    8
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      2202791
      provenance
      batch id
      a86a47b66cb510ab0246
      provider
      NCBI PubMed ESummary
      record sha256
      25490ca3c101a0ba5db409ae01e7e66098c1167a4eda683907981e468f2aa1cf
      response sha256
      62fa1bbcbdc25a5665b7097f6b22fc4289465701bcd0c8efaebd75831ecd761d
      retrieved at
      2026-09-09T23:45:08.918507+00:00
      publication date
      display
      1990 Sep
      precision
      month
      year
      1990
      publication types
      1. Clinical Trial
      2. Comparative Study
      3. Journal Article
      4. Randomized Controlled Trial
      5. Research Support, Non-U.S. Gov't
      6. Research Support, U.S. Gov't, P.H.S.
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/2202791/
      title
      Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15.

      Preserved source evidence · Not medical advice